SPECIAL NOTICE
99 -- Request for Information (RFI) for the National Cancer Institute�s Federally Funded Research and Development Center (FFRDC)/Frederick National Laboratory for Cancer Research (FNLCR)
- Notice Date
- 6/24/2021 1:39:30 PM
- Notice Type
- Special Notice
- NAICS
- 541715
— Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Contracting Office
- NIH National Cancer Institute Rockville MD 20850 USA
- ZIP Code
- 20850
- Solicitation Number
- HHS-NIH-NCI-RFI-MOSB-75N91020R00062-13
- Response Due
- 7/23/2021 1:00:00 PM
- Archive Date
- 08/07/2021
- Point of Contact
- Lisa Bielen, Contracting Officer, Lisa Coleman, Contracting Officer
- E-Mail Address
-
FNLCR_ACQinfo@mail.nih.gov, FNLCR_ACQinfo@mail.nih.gov
(FNLCR_ACQinfo@mail.nih.gov, FNLCR_ACQinfo@mail.nih.gov)
- Description
- BACKGROUND: The National Cancer Institute (NCI) is requesting information from all parties who may be interested in the re-competition of the NCI�s FFRDC.� The FFRDC provides rapid response capabilities and one-of-a-kind resources for the biomedical research community within NCI, NIH and other Federal Agencies. Located in Frederick, MD, the NCI�s FFRDC is a Government-Owned Contractor-Operated (GOCO) research facility with a unique array of research support and advanced technologies, whose purpose is to bridge the gaps from discovery to healthcare delivery; to accelerate the development of new technologies and prototype treatments for patients; and to pave the way for new advances to enter clinical trials for testing, approval, and delivery to patients via the commercial sector. Entities authorized to operate, manage, or administer an FFRDC include: a university, a consortium of universities, other not-for-profit or nonprofit organizations, industrial firms as autonomous organizations (identified separately from any parent organization), or industry/academia partnerships. For more information regarding FNLCR, please refer to the website at http://frederick.cancer.gov/. PURPOSE: The purpose of this Draft RFP (DRFP) is to obtain comments and suggestions from interested parties to improve the solicitation and facilitate an understanding of the Government's requirements. Comments and suggestions may assist in refining or clarifying the Government's Request for Proposals (RFP). The Government does not plan to post responses to any questions or comments pertaining to the DRFP; however, the Government will establish a process for receiving and responding to questions pertaining to the Draft RFP.� 2. DISCLAIMER TO PROSPECTIVE RESPONDENTS: THIS IS A REQUEST FOR INFORMATION (RFI).� This is NOT a solicitation for proposals, capability statements, proposal abstracts, or quotations. The purpose of this RFI is to obtain knowledge and information for project planning purposes. Interested parties are advised that the U.S. Government will not pay for any information or administrative costs incurred in response to this RFI; all costs associated with responding to this RFI will be solely at the interested party�s expense. Respondents are advised that the Government is under no obligation to acknowledge receipt of the information received or provide feedback to respondents with respect to any information submitted. Those not responding to this RFI are not prohibited from participation in any future RFP, if any. If a solicitation is released, it will be synopsized on the Beta.Sam.gov (Beta SAM) in addition to the NCI Office of Acquisition�s website under the FNLCR Acquisition Portal at https://www.cancer.gov/about-nci/contracts/fnlcr-acquisitions/fedbizopps-notices. �Information posted to Beta SAM takes precedence over information provided elsewhere and serves as the Government�s official government-wide point of entry (GPE). 3.� INFORMATION FROM INDUSTRY: Please see the DRFP cover letter for specific instructions on the type of information requested and how feedback may be submitted to the Government. � 4. CONFIDENTIALITY: No proprietary, classified, confidential, or sensitive information should be included in your response. The Government reserves the right to use information provided by respondents for any purpose(s) it deems necessary and legally appropriate.
- Web Link
-
SAM.gov Permalink
(https://beta.sam.gov/opp/c2678561a3954314a912d6aa15dcbb6b/view)
- Place of Performance
- Address: MD, USA
- Country: USA
- Country: USA
- Record
- SN06041421-F 20210626/210624230116 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |